Bionomics Limited (NASDAQ: BNOX)
$0.74
-0.0249 ( -3.25% ) 13.5K
Bionomics Ltd is a global, clinical-stage biopharmaceutical company. It is primarily engaged in the development of therapeutics for diseases of the central nervous system and cancer. The company's reportable segment is the Drug Discovery and Development segment which is engaged in the discovery, development, and commercialization of compounds to match a target product profile. The company generates all of its revenues from Australia.
Market Data
Open
$0.74
Previous close
$0.77
Volume
13.5K
Market cap
$10.09M
Day range
$0.75 - $0.78
52 week range
$0.65 - $6.41
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Quarterly Reports | 6 | Jul 28, 2023 |
6-k | Quarterly Reports | 3 | Jul 25, 2023 |
6-k | Quarterly Reports | 3 | Jul 24, 2023 |
6-k | Quarterly Reports | 10 | Jul 07, 2023 |
6-k | Quarterly Reports | 3 | Jul 07, 2023 |